Welcome to our dedicated page for IonQ SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
Item 5.07 – Results of IonQ’s 2025 Annual Meeting of Stockholders
IonQ, Inc. (NYSE: IONQ) reported the voting outcomes from its 17 June 2025 annual meeting. Two Class I directors were successfully re-elected to serve until the 2028 meeting: Niccolo de Masi received 60,572,382 “For” votes versus 1,986,960 withheld, while Inder M. Singh received 50,750,772 “For” votes versus 11,808,570 withheld. Each proposal carried 52,916,886 broker non-votes.
The non-binding “say-on-pay” proposal passed with 39,900,600 votes in favor (≈64 %), 22,233,654 against (≈35 %), and 425,088 abstentions, suggesting a material minority of shareholders question current compensation practices.
Shareholders overwhelmingly ratified Ernst & Young LLP as independent auditor for FY 2025, delivering 114,159,284 “For” votes (≈99 %), 588,969 against, and 727,975 abstentions.
No other matters were presented and the Form 8-K contained no financial performance updates, transactions, or strategic announcements.
IonQ director William F. Scannell received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Scannell now beneficially owns 140,560 shares directly.
Key details of the RSU grant:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for board service, aligning the director's interests with shareholders through equity ownership. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Gabrielle B. Toledano received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Toledano's direct ownership increased to 6,305 shares.
Key terms of the RSU award:
- Grant was made at $0 exercise price
- RSUs will vest in full at the earlier of:
- 2026 Annual Meeting (or day before if service ends at meeting)
- June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through stock ownership.
IonQ director Inder M. Singh received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Singh now beneficially owns a total of 32,603 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- The RSUs were granted at $0 exercise price
This Form 4 filing represents standard equity compensation for board service, aimed at aligning the director's interests with shareholders. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Kathryn K. Chou received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Chou beneficially owns a total of 67,628 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - 2026 Annual Meeting (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- RSUs were granted at $0 exercise price
This Form 4 filing represents a standard director equity compensation grant, likely part of IonQ's annual board member compensation package. The transaction was executed under normal circumstances with no indication of any Rule 10b5-1 trading plan involvement.
IonQ Director Robert T. Cardillo received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Cardillo's direct ownership increased to 37,436 shares.
Key details of the RSU award:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing, executed by Attorney-in-Fact Stacey Giamalis, represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through equity ownership.
IonQ Chief Financial Officer Thomas G. Kramer has executed a significant stock transaction on June 16, 2025, selling 216,000 shares of common stock at a weighted average price of $38.1131 per share. The transaction was conducted through a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025.
Following the transaction, Kramer retains direct ownership of 718,516 shares and indirect ownership of 5 shares through his child. The sales were executed at prices ranging from $36.07 to $39.14 per share.
Key transaction details:
- Transaction was executed pursuant to a Rule 10b5-1 plan, indicating pre-planned, scheduled trading activity
- Total transaction value approximately $8.23 million
- Significant retained ownership position indicates continued alignment with shareholder interests
- Filing was signed by attorney-in-fact Stacey Giamalis on June 18, 2025
IonQ Executive Chair Peter Chapman reported significant insider transactions executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025. The transactions occurred over two consecutive days:
- On June 16, 2025: Exercised 3,581,193 stock options at $0.1334 per share and subsequently sold them at an average price of $38.126
- On June 17, 2025: Exercised 910,740 stock options at $0.1334 per share and sold them at an average price of $37.7787
Following these transactions, Chapman retains 390,329 shares of common stock held directly and 1,604,972 vested stock options exercisable until May 16, 2029. The substantial price difference between the exercise price ($0.1334) and sale prices (>$36) resulted in significant gains. These pre-planned sales may indicate portfolio diversification rather than a lack of confidence in the company.